Hepatitis: all 3,372 studies
Page 34 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
- Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access ProgramNo longer availableNCT00096811
- Adult-to-Adult Living Donor Liver Transplantation StudyCompletedNCT00096733
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNCT00093093Phase 3
- Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis CCompletedNCT00088504Phase 2
- A Caspase Inhibitor in Chronic Hepatitis C (HCV) PatientsCompletedNCT00088140Phase 2
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00086541Phase 3
- CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
- Leukapheresis for Research on HCV-Coinfected PatientsCompletedNCT00076427
- Racial Difference in HCV/Host InteractionsCompletedNCT00071916
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis BCompletedNCT00071201Phase 3
- 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.Status unknownNCT00069511Phase 2
- Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two DrugsCompletedNCT00062816Phase 1/2
- Hepatitis C: Grading and Staging by MRCompletedNCT00059397
- Prevention of Recurrent Hepatitis B After Liver TransplantationCompletedNCT00059267
- Treatment of Cholestatic Pruritus With SertralineCompletedNCT00058903Phase 2
- A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BCompletedNCT00057265Phase 3
- IdB 1016 Treatment for Hepatitis C DiseaseCompletedNCT00055445Phase 1/2
- Treatment of Hepatitis C in Hemophilic Patients With HIVCompletedNCT00055341Phase 2
- Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
- Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected PatientsCompletedNCT00051038Phase 2/3
- Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic AnemiaCompletedNCT00050115
- Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis BCompletedNCT00048945Phase 3
- Study of FK788 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00047814Phase 2
- A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.Status unknownNCT00044135Phase 2
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
- An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNCT00042393
- Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNCT00040144Phase 2
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00040027Phase 3
- Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00039962Phase 3
- Hepatitis C Antiviral Resistance in African-AmericansCompletedNCT00038974Phase 3
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
- Prevalence of Hepatitis C Virus Infection in HIV-Infected ChildrenCompletedNCT00037076
- A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineCompletedNCT00036608Phase 3
- ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus InfectionsCompletedNCT00035945Phase 2
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenCompletedNCT00035789Phase 3
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenCompletedNCT00035633Phase 3
- Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionCompletedNCT00034359Phase 2
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
- The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinCompletedNCT00031343Phase 2
- Evaluating Silymarin for Chronic Hepatitis CCompletedNCT00030030Phase 2
- Gamma Interferon Therapy for Chronic Hepatitis CCompletedNCT00028275Phase 2
- Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
- Study of Transfusion-Transmitted InfectionsCompletedNCT00023023
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
- Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedNCT00013702Phase 2
- Herbal Treatment of Hepatitis C in Methadone Maintained PatientsCompletedNCT00010816Phase 2
- A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00008463Phase 2
- To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).CompletedNCT00007709
- Hepatitis C in Clinically Discordant Hemophilic SiblingsCompletedNCT00007371
- Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C VirusCompletedNCT00006643
- Immune Response to Hepatitis C VirusCompletedNCT00006301
- Genetics of Hepatitis C Virus InfectionCompletedNCT00005657
- Risk of Post Transfusion Hepatitis C Virus InfectionCompletedNCT00005339
- Natural History of Post-transfusion Non-A, Non-B HepatitisCompletedNCT00005306
- Hepatitis Delta Infections in HemophiliacsCompletedNCT00005305
- Delta Hepatitis and Liver Disease in HemophiliacsCompletedNCT00005304
- A Controlled Prospective Study of Transfusion-Associated HepatitisCompletedNCT00004848
- Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
- History of Hepatitis C in Volunteer Blood DonorsCompletedNCT00001982
- Collections of Blood and Stool Samples in Patients With Acute HepatitisCompletedNCT00001879
- Long-Term Therapy With Ribavirin for Chronic Hepatitis CCompletedNCT00001854Phase 4
- Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
- Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanCompletedNCT00001712
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2
- A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C InfectionCompletedNCT00001117
- The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNCT00001035Phase 1
- The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUCompletedNCT00000654Phase 2
- Hepatitis B Vaccine Clinical TrialCompletedNCT00000583Phase 3
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3